Clinical trial
Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated…
NCT00004315 · National Center for Research Resources (NCRR), NIH · Unknown status
Key facts
| NCT number | NCT00004315 |
|---|---|
| Title | Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Children's Hospital Medical Center, Cincinnati |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis, Gastrointestinal Diseases, Cholestasis |
| Intervention type | Drug |
| Interventions | ursodiol |
| Enrollment | 20 |
| Start date | Nov 1, 1995 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: